Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 2

1(16.7%)

6Total

N/A(5)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06137378Phase 2Recruiting

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

Role: collaborator

NCT05716815Not ApplicableNot Yet Recruiting

Prospective rAndomized sTudy efficaCy tHree-dimensional rEconstructions Segmentectomy

Role: collaborator

NCT04929730Not ApplicableUnknown

Effect of Medical Care on Health Status in Acute Kidney Injury

Role: collaborator

NCT02554292Completed

Post Market Surveillance of SeQuent Please Neo With Scoring Balloon

Role: collaborator

NCT02402985Not ApplicableCompleted

Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics

Role: collaborator

NCT01681173Not ApplicableCompleted

OPTIFIT-Optimal Fiber Trial for Diabetes Prevention

Role: collaborator

NCT01631123Not ApplicableCompleted

NUtriGenomic Analysis in Twins

Role: collaborator

All 7 trials loaded